Press release

Notification of Full Year Results Date

6 April 2017

e-Therapeutics plc (AIM: ETX), the drug discovery company, will announce its full year results for the year ended 31 January 2017 on Wednesday, 19 April 2017.

Tags
Share
Sign up for press releases

Discover

Whats New?

Explore more

Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate

Nov 26, 2025

Tangram Therapeutics to Participate in Upcoming Investor and Scientific Conferences

Oct 3, 2025

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Oct 1, 2025

e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with Positive Non-clinical Data

Jul 10, 2025

e-therapeutics presents new data supporting ETX‑312 as a differentiated, disease-modifying near-clinic GalOmic Treatment for MASH

May 7, 2025

e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025

Feb 5, 2025

/